The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial | Goomedic.com
Links shared publicly online about this topic.
- 1,275total visits
The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial | Goomedic.com
View full resource at goomedic.com
Tags: Cancer, Breast Cancer, Clinical Trial, Women's Health, Medical
Most Recently Shared on March 31, 2010 at 7:15 am By:
The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial http://is.gd/b7N58
The Biomarkers Consortium Launches I-SPY 2 Breast Cancer Clinical Trial | Business Wire
businesswire.com — “BETHESDA, Md.--(BUSINESS WIRE)--The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an im” View full resource at businesswire.com
Most Recently Shared on March 17, 2010 at 5:06 pm By:
I-SPY 2 breast cancer trial aims for quicker testing of new drugs http://tinyurl.com/y9fsg6w & http://tinyurl.com/ycmsa7r
Advertisement
